Sano Genetics, a startup helping with Long Covid research, raises £2.5M in seed funding – TechCrunch
Sano Genetics, a startup with a broad mission to support personalised medicine research by increasing participation in clinical trials, has raised £2.5 million in seed funding. Sano Genetics says part of the new capital will be to fund free at-home DNA testing kits for 3,000 people affected by Long Covid. “For participants in medical research, the process is not user friendly,” says Sano Genetics CEO Patrick Short. “[Therefore], for researchers in biotech, pharma, and academia, it is very difficult to attract and retain research participants, which adds substantial costs and time to their research. Meanwhile, Sano Genetics generates revenue by charging biotech and pharma companies fees to find the right patients for their studies.